3
Participants
Start Date
February 29, 2000
Primary Completion Date
August 31, 2001
Study Completion Date
July 31, 2002
HER-2/neu intracellular domain protein
therapeutic autologous dendritic cells
Duke Comprehensive Cancer Center, Durham
Lead Sponsor
National Cancer Institute (NCI)
NIH
Duke University
OTHER